Wealth Enhancement Advisory Services LLC Has $240,000 Stock Holdings in Abrdn Life Sciences Investors (NYSE:HQL)

Wealth Enhancement Advisory Services LLC lowered its position in shares of Abrdn Life Sciences Investors (NYSE:HQL) by 19.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,932 shares of the company’s stock after selling 3,851 shares during the period. Wealth Enhancement Advisory Services LLC owned 0.06% of Abrdn Life Sciences Investors worth $240,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Future Financial Wealth Managment LLC acquired a new position in Abrdn Life Sciences Investors in the 3rd quarter worth about $30,000. B. Riley Wealth Advisors Inc. acquired a new position in Abrdn Life Sciences Investors during the 1st quarter worth approximately $143,000. Sanctuary Advisors LLC acquired a new stake in Abrdn Life Sciences Investors in the 2nd quarter valued at $154,000. International Assets Investment Management LLC bought a new stake in shares of Abrdn Life Sciences Investors during the third quarter worth about $204,000. Finally, Wedbush Securities Inc. raised its stake in shares of Abrdn Life Sciences Investors by 8.2% in the second quarter. Wedbush Securities Inc. now owns 16,673 shares of the company’s stock worth $236,000 after purchasing an additional 1,261 shares during the last quarter. Institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Stock Up 0.2 %

Shares of HQL stock opened at $15.25 on Tuesday. The company has a 50-day simple moving average of $15.03 and a two-hundred day simple moving average of $14.63. Abrdn Life Sciences Investors has a 52-week low of $11.62 and a 52-week high of $15.90.

Abrdn Life Sciences Investors Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.